Brain cancer exemption advances in both chambers
March 3, 2022 - Efforts by Associated Industries of Missouri to obtain an exemption from sales and use taxes for items used to control the growth of tumors in terminal brain cancer patients advanced this week in both the Missouri House and Missouri Senate.
The House Rules - Administrative Oversight Committee approved HB 1864, filed by Rep. Lisa Thomas, that would clarify the exemption of such devices. Rep. Thomas sponsored the same language in an amendment to another bill last session that was vetoed by Governor Mike Parson because of other items in the bill. The unanimous vote will mean HB 1864 may now be placed on the calendar for debate by the full Missouri House of Representatives as early as next week.
The Senate Ways and Means Committee also held a hearing on SB 943, filed by the Chairman of the Committee, Sen. Andrew Koenig. The bill is identical to HB 1864.
"This legislation follows multiple legislative and administrative attempts to secure this exemption that affects the lives and pocketbooks of terminal cancer patients," said Ray McCarty, president and CEO of Associated Industries of Missouri. "We believe the State of Missouri can find much better items to tax than taxing cancer treatment devices. These items help provide an average of five additional months of life for patients using the device - and while five months may not seem like a long time, it is a long time for terminal cancer patients," said McCarty as he testified in support of SB 943.
The Committee could vote on the bill as early as next week. We will keep you updated on the progress of both bills.